Todd Grinnell

Sumitomo Dainippon Pharma (United States) — United States

Medicine · Health Sciences

11h-index497citations82works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(74), Pharmacological Effects and Toxicity Studies(50), Neuroscience and Neuropharmacology Research(21), Pharmaceutical studies and practices(19), EEG and Brain-Computer Interfaces(10)

Publications82 total

Seizure monitoring by combined diary and wearable data: A multicenter, longitudinal, observational study
Epilepsia·2025· 3 cited
Efficacy, safety, and tolerability of adjunctive eslicarbazepine acetate in patients with focal to bilateral tonic-clonic seizures
Epilepsy Research·2023· 1 cited
Time to sustained responder status in patients with focal seizures treated with adjunctive eslicarbazepine acetate
Epilepsy Research·2023· 1 cited
Long-term quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate
Epilepsy & Behavior·2023Open Access
Long-Term Quality of Life in Patients With Focal Seizures Treated With ESL: Pooled Analysis From 3 Phase III Open-Label Extension Studies (P11-1.009)
Neurology·2023
Efficacy, Safety, and Tolerability of Adjunctive Eslicarbazepine Acetate in Focal Seizure Patients With Focal to Bilateral Tonic-Clonic Seizures at Baseline (P14-1.003)
Neurology·2023
Real-World Evaluation of Serum Sodium Levels in Patients With Focal Seizures Treated With Eslicarbazepine Acetate (P4-1.010)
Neurology·2023
The economic and humanistic burden of bipolar disorder in adults in the United States
Annals of General Psychiatry·2023· 30 citedOpen Access
Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial
Clinical Neurology and Neurosurgery·2022· 4 cited
Psychiatric adverse events in three phase <scp>III</scp> trials of eslicarbazepine acetate for focal seizures
Epilepsia Open·2022· 5 citedOpen Access
Implementing Digital Technologies in Clinical Trials: Lessons Learned.
PubMed·2022· 12 citedOpen Access
PND6 Comparative Economic Outcomes in Patients with Focal Seizures Initiating Adjunctive Eslicarbazepine Acetate Versus Brivaracetam As Their First Adjunctive Branded ASD
Value in Health·2021Open Access
Efficacy of Adjunctive Eslicarbazepine Acetate in Patients with Focal Seizures, According to Baseline Seizure Frequency: A Post-Hoc Analysis of Data from a Phase IV Clinical Trial (4174)
Neurology·2021
Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs
ClinicoEconomics and Outcomes Research·2021· 2 citedOpen Access
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
Epilepsy Research·2021· 12 citedOpen Access
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD
Journal of Medical Economics·2021· 2 citedOpen Access
Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18–59 years) adults
Epilepsy Research·2020· 5 citedOpen Access
Long-term safety and tolerability of adjunctive eslicarbazepine acetate in children with focal seizures
Epilepsy & Behavior·2020· 6 citedOpen Access
Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses
Neurology and Therapy·2020· 9 citedOpen Access
Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial results
Epilepsy & Behavior·2020· 8 cited
page 1 of 5Next →

Frequent Co-authors

David Blum(35), David Cantu(13), Hailong Cheng(11), Joana Moreira(9), Patrício Soares‐da‐Silva(9), Helena Gama(8), Michael R. Sperling(7), Eugen Trinka(6), Ronald N. Marcus(6), Jay Harvey(5), Mercedes Jacobson(5), Barry E. Gidal(5), Mar Carreño(5), Darshan Mehta(5), Mariana Vieira(5), Robert Tosiello(5), Joanne Rogin(4), Gregory L. Krauss(4), Laura Strom(4), Robert Wechsler(4)